Brainstorm Cell Therapeutics Inc. (BCLI)
NASDAQ: BCLI · Real-Time Price · USD
1.190
-0.070 (-5.56%)
At close: Apr 1, 2025, 4:00 PM
1.183
-0.007 (-0.61%)
After-hours: Apr 1, 2025, 4:35 PM EDT

BCLI Stock Forecast

BCLI's stock price has decreased by -85.95% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 1 analyst with a 12-month price forecast for BCLI stock has a target of 30, which predicts an increase of 2,421.01% from the current stock price of 1.19.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $30 $30 $30 $30
Change +2421.0% +2421.0% +2421.0% +2421.0%
* Price targets were last updated on Jul 11, 2024.

Analyst Ratings

According to 1 stock analyst, the rating for BCLI is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Nov '24Dec '24Jan '25Feb '25Mar '25
Strong Buy 11111
Buy 00000
Hold 00000
Sell 00000
Strong Sell 00000
Total 11111

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Maxim Group
Maxim Group
Strong Buy
Upgrades
$30
Strong Buy Upgrades $30 +2,421.01% Jul 11, 2024
Maxim Group
Maxim Group
Hold
Downgrades
n/a
Hold Downgrades n/a n/a Sep 28, 2023
Maxim Group
Maxim Group
Strong Buy
Maintains
$75$150
Strong Buy Maintains $75$150 +12,505.04% Mar 31, 2023
Maxim Group
Maxim Group
Strong Buy
Upgrades
n/a
Strong Buy Upgrades n/a n/a Feb 5, 2021
Maxim Group
Maxim Group
Strong Buy
Maintains
$120$135
Strong Buy Maintains $120$135 +11,244.54% Aug 17, 2017
More Analyst Ratings

Financial Forecast

Revenue This Year
232.66M
from 86.14M
Increased by 170.09%
Revenue Next Year
n/a
from 232.66M
EPS This Year
-2.61
from -6.00
EPS Next Year
-1.59
from -2.61
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027 FY 2028 FY 2029
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027 Dec 31, 2028 Dec 31, 2029
Revenue
----86.14M232.66M
Revenue Growth
-----170.09%--
EPS
-15.92-15.99-10.20-9.97-6.00-2.61-1.59-1.26
EPS Growth
--------
Forward PE
--------
No. Analysts -----544
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202420252026202720282029
High n/a n/a n/a
Avg n/a n/a n/a
Low n/a n/a n/a

Revenue Growth

Revenue Growth 202420252026202720282029
High - - -
Avg - - -
Low - - -

EPS Forecast

EPS 202420252026202720282029
High -2.21 -1.60 -1.20
Avg -2.61 -1.59 -1.26
Low -2.95 -1.57 -1.30

EPS Growth

EPS Growth 202420252026202720282029
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.